World news and discussion on TalkFuse.
Woman who says abortion pills nearly killed her urges RFK Jr to act as group demands mail-order crackdown
Haile McAnally is urging Health Secretary Robert F. Kennedy Jr. to reinstate in-person dispensing of mifepristone, saying mail-order access could put women’s safety at risk. Her appeal follows a letter from Susan B. Anthony Pro-Life America calling for the change while the Food and Drug Administration reviews the drug.
McAnally says she suffered severe bleeding after taking abortion pills at a clinic 14 years ago and needed a blood transfusion. The group argues Kennedy can suspend drug approval changes if he finds an imminent public-health hazard, citing a Justice Department filing about the FDA’s 2023 changes that allowed mifepristone to be dispensed by mail. The article also cites a 2025 conservative think-tank study reporting serious adverse events in 10.93% of women within 45 days, a finding presented by the group in support of tighter oversight.
In short
- McAnally wants mail-order access to mifepristone restricted.
- SBA Pro-Life America urges Kennedy to restore in-person dispensing.
- A cited study reports serious adverse events in 10.93% of women.
Steelman: both sides, in good faith
The strongest fair case each way — we don't pick a winner.
The case for
Supporters of reinstating in-person dispensing argue that mifepristone can involve serious complications, as McAnally’s experience illustrates, and that face-to-face care may help ensure patients receive appropriate screening, instructions and follow-up. While the FDA reviews the drug, they say, restoring the earlier dispensing rules would be a prudent safeguard, particularly if the cited study’s higher estimate of adverse events is borne out.
The case against
Opponents of a mail-order crackdown argue that access by post can make medication abortion more practical for people who live far from clinics, have limited resources or need privacy, without removing access to clinical support. They would point to the FDA’s review and the need to assess the cited study’s methods and findings before changing policy, and argue that one person’s severe complication does not by itself establish that mail dispensing creates an unacceptable public-health risk.
Explained simply
Mifepristone is a medicine used in most medication abortions in the United States, usually alongside a second drug. US rules have changed over time to allow it to be prescribed and dispensed without an in-person visit, including by post.
The Food and Drug Administration (FDA), which regulates medicines, is reviewing mifepristone. Health Secretary Robert F. Kennedy Jr oversees the department that includes the FDA. Susan B. Anthony Pro-Life America opposes abortion and is asking him to restore in-person dispensing; Haile McAnally says she had severe bleeding after taking abortion pills and needed a blood transfusion.
The dispute concerns how access to the medicine should be balanced with oversight of its use and possible risks. The FDA’s review and the legal rules around the drug could affect how people obtain it across the country.